Current concepts in the management of acute ischemic stroke

Journal of Association of Physicians of India

Volumn 50, Issue 3, 2002, Pages 407-414

  Sareen, D ^a  

^a ST STEPHEN S HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANCROD; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; NEUROPROTECTIVE AGENT;

ADULT; BRAIN ISCHEMIA; CLINICAL TRIAL; DRUG EFFECT; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL PRESSURE; PATHOPHYSIOLOGY; REVIEW;

ADULT; ANCROD; ANTICOAGULANTS; BRAIN ISCHEMIA; CLINICAL TRIALS; FIBRINOLYTIC AGENTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL PRESSURE; NEUROPROTECTIVE AGENTS;

EID: 0036515202     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Caplan LR. Stroke : A clinical approach. 2nd edition, Boston, Mass : Butterworth-Heinemann. 1993.
2. Pulsinelli W. Pathophysiology of acute ischemic stroke. Lancet 1992;339:533-6.
3. De Keyser J, Sulter G, Luiten PAG. Clinical trials with neuroprotective drugs in acute ischemic stroke : are we doing the right thing? Trends Neurosci 1999;22:535-40.
4. The NINDS tPA Stroke Study Group. Generalized efficacy of tPA for acute stroke : Subgroup analysis of the NINDS tPA Stroke Trial. Stroke 1997;28:2119-25.
5. Hacke W, Kaste M, Fieschi C. Intravenous stroke. The European cooperative acute stroke study (ECASS). JAMA 1995;274:1017-25.
6. Hacke W, Kaste M, Fieschi C. Randomized double-blind, placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 1998;352:1245-51.
7. Albers GW, Clark WM, for the ATLANTIS Study Investigators. The ATLANTIS rt-PA (Alteplase) acute stroke trial : final results. Cerebrovasc Dis 1999;9:126 (abstract).
8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
9. NINDS tPA Stroke Study Group. Intracerebral hemorrhage after intravenous tPA therapy for ischemic stroke. Stroke 1997;28:2109-18.
10. Tanne D, Hansback H, Verro P. Intravenous rt-PA therapy in stroke in clinical practice : a multicentre evaluation of outcome. Stroke 1998;29:288.
11. Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke : NINDS rt-PA Stroke Study Group. Neurology 1998;50:889-90.
12. Practice Advisory. Thrombolytic therapy for acute ischemic stroke-summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996;47:835-9.
13. Haroid P, Thomas G, from a Special Writing Group of the Stroke Council, American Heart Association. Guidelines for thrombolytic therapy for acute stroke : A supplement to the guidelines for the management of patients with acute ischemic stroke. Circulation 1996;94:1167-74.
14. del Zoppo G, Poeck K, Pessin M. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-85.
15. del Zoppo G, Higashida R, Furlan A. A phase II randomized trial of recombinant prourokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11.
16. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Pessin M, Ahuja A, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study : A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-11.
17. Wijdicks EF, Nichols DA, Thielen KR, Fulgham JR, Brown RD, Meissner I, et al. Intra-arterial thrombolysis in acute basilar artery thromboembolism : the initial Mayo Clinic experience. Mayo Clin Proc 1997;72:1005-13.
18. Mitchell P, Gerraty R, Donnan G. Thrombolysis in the vertebrobasilar circulation : the Australian Urokinase Stroke Trial. Cerebrovasc Dis 1997;7:94-9.
19. Sasaki O, Takeuchi S, Koike T, Koizumi T, Tanaka R. Fibrinolytic therapy for acute embolie stroke : intravenous, intracarotid, and intra-arterial local approaches. Neurosurgery 1995;36:246-53.
20. Brott T, Broderick J, Kothari R. Thrombolytic therapy for stroke. Curr Opin Neural 1994;7:25-35.
21. Sherman DG, Atkinson RP, Chippendale T, Levin KA, Ng K, Futrell N, et al. Intravenous ancrod for treatment of acute ischemic stroke : the STAT study : a randomized controlled trial. Stroke Treatment with Ancrod Trial. JAMA 2000;283:2395-2403.
22. Horn J, Haan R, Vermeulen M. VENUS - very early nimodipine use in stroke : Preliminary trial results. 24th American Heart Association International Conference on Stroke and Cerebral. Nashville, TN. 1999.
23. De Deyn PP, De Reuck J, Deberdt W, Vlietinck R, Orgogozo JM for Members of the Piracetam in Acute Stroke Study (PASS) Group. Treatment of acute ischemic stroke with piracetam. Stroke 1997;28:2347-52.
24. Wang Y, Lynette L, Levi C, Heller RF, Fisher J. Influence of admission body temperature on stroke mortality. Stroke 2000;31:404-9.
25. Hajat C, Hajat S, Sharma P. Effect of poststroke pyrexia on stroke outcome : A meta-analysis of studies in patients. Stroke 2000;31:410-14.
26. Hakim AM, Furlan AJ, Hart RG. Immediate anticoagulation of embolie stroke : a randomized trial : the Cerebral Embolism Study Group. Stroke 1983;14:668-76.
27. Sandercock P. Is there still a role for intravenous heparin in acute stroke? Arch Neurol 1999;56:1160-1.
28. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172, and outcome after acute ischemic stroke : a randamized controlled trial. JAMA 1998;279:1265-72.
29. International Stroke Trial Collaborative Group. A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. Lancet 1997;349:1569-81.
30. Gubitz G, Counsell C, Sandercock P, Signorini D. Anticoagulants for acute ischemic stroke. Cochrane Database Syst Rev 2000; 2):Update Software.
31. Hachinski V. Intravenous heparin in acute stroke. Archives of Neurology 1999;56:1162.
32. Adams H, Brott T, Crowell R, et al. AHA medical/scientific statement - guidelines for management of patients with acute ischemic stroke : A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 1994;25:1901-14.
33. Broderick J, Brott T, Rarsan W. Blood pressure during the first minutes of focal cerebral ischemia. Ann Emerg Med 1993;22:1438-43.
34. Hatashita S, Hoff J, Ishil S. Focal brain edema associated with acute arterial hypertension. J Neurosurg 1986;64:643-9.
35. Grossman E, Messerli F, Grodzicki T, et al. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996;276:1328-31.
36. Ropper AH, Schwarz B. Brain edema after stroke. Arch Neurol 1984;41:26-9.
37. Schwab S, Schwarz, Spranger M, Keller E, Hacke W. Barbiturate coma in severe hemispheric stroke : useful or obsolete? Neurology 1997;48:1608-13.
38. Schwab S, Hacke W. Therapy of increased intracranial pressure in space-occupying media infarcts. Z Arzti Eortbild Qualitatssich 1999;93:203-8.
39. Schwab S, Schwarz, Spranger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998;29:2461-6.
40. Mikel HS, Yashes NV, Kempinski O, von Lubitz D, Weiss JF, Feuerstein G. Breathing 100% oxygen after global brain ischaemia in monogolian gerbils results in increased lipid peroxidation and increased mortality. Stroke 1987;18:426-30.
41. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an indepdendent predictor of poor outcome after acute stroke? Results of a long term follow up study. Brit Med J 1997;314:1303-6.
42. Wass CT, Lanier WL. Glucose modulation of ischaemic brain injury : review and clinical recommendations. Mayo Clin Proc 1996;71:801-12.
43. Gubitz G, Sandercock P, Counsell C. Antiplatelet therapy for acute ischemic stroke. Cochrane Database Syst Rev 2000;(2):Update software.
44. CAST (Chinese acute stroke trial) Collaborative Group. CAST : Randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 1997;349:1641-9.
45. Ciuffetti G, Aisa G, Mercuri M. Effects of ticlopidine on the neurologic pattern and the hemorheologic pattern in the postacute phase of ischemic stroke : a pilot study. Angioplasty 1990;41:505-11.
46. Majid A, Delanty N, Kantor J. Antiplatelet agents for secondary prevention of ischemic stroke. Ann Pharmacother 2001;35:1241-7.
47. Boneu B, Destelle G. Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thromb Haemost 1996;76:939-43.